Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124862402 | 12486240 | 2 | F | 20160504 | 20160810 | 20160621 | 20160817 | EXP | IT-MINISAL02-363459 | IT-MYLANLABS-2016M1025528 | MYLAN | 0.00 | Y | 0.00000 | 20160817 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124862402 | 12486240 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 50 MG, QD | 18487 | 50 | MG | TABLET | QD | ||||||
| 124862402 | 12486240 | 2 | SS | ENALAPRIL | ENALAPRIL | 1 | Oral | 10 MG, MONTHLY | 0 | 10 | MG | /month | |||||||
| 124862402 | 12486240 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | FILM-COATED TABLET | QD | ||||||
| 124862402 | 12486240 | 4 | C | TAPAZOLE | METHIMAZOLE | 1 | Oral | 0 | TABLET | ||||||||||
| 124862402 | 12486240 | 5 | C | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG, UNK | 0 | 220 | MG | CAPSULE, HARD | |||||||
| 124862402 | 12486240 | 6 | C | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124862402 | 12486240 | 1 | Cardiac failure |
| 124862402 | 12486240 | 2 | Cardiac failure |
| 124862402 | 12486240 | 3 | Psychotic disorder |
| 124862402 | 12486240 | 4 | Hyperthyroidism |
| 124862402 | 12486240 | 5 | Atrial fibrillation |
| 124862402 | 12486240 | 6 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124862402 | 12486240 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124862402 | 12486240 | Blood calcium decreased | |
| 124862402 | 12486240 | Hyponatraemia | |
| 124862402 | 12486240 | Psychomotor retardation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124862402 | 12486240 | 5 | 20151101 | 20160504 | 0 |